Holen Sie sich die Stockscreener-App
16.62
0.18%
0.03
Handel nachbörslich:
16.51
-0.11
-0.66%
Novocure Ltd Aktie (NVCR) Neueste Nachrichten
Novocure's COO Mukund sells shares worth $2,540 - Investing.com
Novocure's oncology president sells $9,530 in shares - Investing.com
Michal Nath Puri Sells 810 Shares of NovoCure Limited (NASDAQ:NVCR) Stock - MarketBeat
Novocure's oncology president sells $9,530 in shares By Investing.com - Investing.com Australia
Novocure's COO Mukund sells shares worth $2,540 By Investing.com - Investing.com Australia
NovoCure Ltd (NVCR) Shares Up 3.96% on Nov 4 - GuruFocus.com
FY2024 EPS Estimates for NovoCure Raised by HC Wainwright - MarketBeat
Analyst Estimates: Here's What Brokers Think Of NovoCure Limited (NASDAQ:NVCR) After Its Third-Quarter Report - Simply Wall St
NovoCure Limited (NASDAQ:NVCR) Q3 2024 Earnings Call Transcript - Insider Monkey
NovoCure shares hold Buy rating, steady price target post-earnings - Investing.com
NovoCure shares hold Buy rating, steady price target post-earnings By Investing.com - Investing.com UK
NovoCure's (NVCR) Buy Rating Reiterated at HC Wainwright - MarketBeat
NovoCure’s Strong Q3 and Leadership Changes in 2024 - Yahoo Finance
NovoCure: Q3 Earnings Snapshot - Milford Mirror
NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
NovoCure Ltd (NVCR) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid Strategic ... - Yahoo Finance
Novocure names Christoph Brackmann as new CFO - Investing.com India
Novocure’s Q3 2024 Results Highlight Growth and Innovation - TipRanks
NovoCure (NASDAQ:NVCR) Stock Price Down 7.1%Should You Sell? - MarketBeat
Novocure Ltd earnings beat by $0.05, revenue topped estimates - Investing.com
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates - Yahoo Finance
Novocure Appoints Christoph Brackmann as Chief Financial Officer - Yahoo Finance
Novocure Reports Third Quarter 2024 Financial Results - Yahoo Finance
Semanteon Capital Management LP Makes New Investment in NovoCure Limited (NASDAQ:NVCR) - MarketBeat
NovoCure Limited (NASDAQ:NVCR) Shares Sold by SG Americas Securities LLC - MarketBeat
Novocure shares soar 33% as FDA approves lung cancer treatment - MSN
Leerink Partnrs Forecasts Stronger Earnings for NovoCure - MarketBeat
NovoCure scoops FDA approval on wearable for metastatic cancer treatment - Medical Device Network
Novocure's Optune Lua Receives FDA Approval For Lung Cancer Treatment - Yahoo Finance
Novocure scoops FDA approval for electric field lung cancer treatment device - Mugglehead
Deep Dive Into NovoCure Stock: Analyst Perspectives (4 Ratings) - Benzinga
NovoCure Ltd (NVCR) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle
NovoCure (NASDAQ:NVCR) Shares Gap UpTime to Buy? - MarketBeat
Novocure wins FDA approval for electric field device in lung cancer - BioPharma Dive
A new trading data show NovoCure Ltd (NVCR) is showing positive returns. - SETE News
NovoCure Ltd (NVCR)’s Market Momentum: Closing Strong at 17.78, Up 10.71 - The Dwinnex
NovoCure: There Is Still More Upside (Rating Upgrade) (NASDAQ:NVCR) - Seeking Alpha
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class ActionNVCR - AsiaOne
NovoCure stock upgraded to buy, price target set on recent FDA approval - Investing.com
NovoCure stock upgraded to buy, price target set on recent FDA approval By Investing.com - Investing.com South Africa
NovoCure (NASDAQ:NVCR) Rating Increased to Buy at HC Wainwright - MarketBeat
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients - Yahoo Finance
Novocure shares soar 33% as FDA approves lung cancer treatment By Investing.com - Investing.com South Africa
Novocure jumps on FDA approval for lung cancer treatment - XM
NovoCure (NVCR) Surges 10.7%: Is This an Indication of Further Gains? - Yahoo Finance
NovoCure Breaks Above 200-Day Moving AverageBullish for NVCR - Nasdaq
FDA Approves Novocure’s Optune Lua® for the Treatment of Metastatic Non-Small Cell Lung Cancer - Yahoo Finance
After-hours movers: United Airlines, Interactive Brokers, J.B. Hunt and more - StreetInsider.com
How did NovoCure Ltd (NVCR) fare last session? - US Post News
The time has not yet come to remove your chips from the table: NovoCure Ltd (NVCR) - SETE News
NovoCure Ltd (NVCR) shows promising results - US Post News
Gaining Ground: NovoCure Ltd (NVCR) Closes Higher at 14.66, Up 0.34 - The Dwinnex
Analyzing NovoCure Ltd (NVCR) After Recent Trading Activity - Knox Daily
NovoCure Limited (NASDAQ:NVCR) Position Boosted by The Manufacturers Life Insurance Company - MarketBeat
A Tale of Resilience: NovoCure Ltd Amid Stock Market Turbulence - The InvestChronicle
AQR Capital Management LLC Acquires 302,351 Shares of NovoCure Limited (NASDAQ:NVCR) - MarketBeat
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):